| Product Code: ETC6142853 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Neuroendocrine Tumors Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Neuroendocrine Tumors Market - Industry Life Cycle |
3.4 Argentina Neuroendocrine Tumors Market - Porter's Five Forces |
3.5 Argentina Neuroendocrine Tumors Market Revenues & Volume Share, By Classification, 2021 & 2031F |
3.6 Argentina Neuroendocrine Tumors Market Revenues & Volume Share, By Site, 2021 & 2031F |
3.7 Argentina Neuroendocrine Tumors Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.8 Argentina Neuroendocrine Tumors Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 Argentina Neuroendocrine Tumors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 Argentina Neuroendocrine Tumors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Argentina Neuroendocrine Tumors Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Argentina Neuroendocrine Tumors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroendocrine tumors in Argentina |
4.2.2 Technological advancements in diagnosis and treatment methods |
4.2.3 Growing awareness among healthcare professionals and patients about neuroendocrine tumors |
4.3 Market Restraints |
4.3.1 High treatment costs associated with neuroendocrine tumors |
4.3.2 Limited access to specialized healthcare facilities for diagnosis and treatment |
4.3.3 Regulatory challenges impacting the approval and availability of novel therapies |
5 Argentina Neuroendocrine Tumors Market Trends |
6 Argentina Neuroendocrine Tumors Market, By Types |
6.1 Argentina Neuroendocrine Tumors Market, By Classification |
6.1.1 Overview and Analysis |
6.1.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Classification, 2021- 2031F |
6.1.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Functional Net, 2021- 2031F |
6.1.4 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Non-Functional Net, 2021- 2031F |
6.2 Argentina Neuroendocrine Tumors Market, By Site |
6.2.1 Overview and Analysis |
6.2.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.4 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Gastrointestinal Tract (GI), 2021- 2031F |
6.2.5 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Appendicular, 2021- 2031F |
6.3 Argentina Neuroendocrine Tumors Market, By Grade |
6.3.1 Overview and Analysis |
6.3.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Grade 1, 2021- 2031F |
6.3.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Low-Grade Tumor, 2021- 2031F |
6.3.4 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Grade 2, 2021- 2031F |
6.3.5 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Intermediate-Grade Tumor, 2021- 2031F |
6.3.6 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Grade 3, 2021- 2031F |
6.3.7 Argentina Neuroendocrine Tumors Market Revenues & Volume, By High-Grade Tumor, 2021- 2031F |
6.4 Argentina Neuroendocrine Tumors Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Treatment, 2021- 2031F |
6.5 Argentina Neuroendocrine Tumors Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.5.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.5.4 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021- 2031F |
6.5.5 Argentina Neuroendocrine Tumors Market Revenues & Volume, By mTOR Inhibitors, 2021- 2031F |
6.5.6 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.5.7 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.5.8 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.5.9 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.6 Argentina Neuroendocrine Tumors Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.7 Argentina Neuroendocrine Tumors Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.7.4 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.5 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.6 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Argentina Neuroendocrine Tumors Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.8.4 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.5 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.6 Argentina Neuroendocrine Tumors Market Revenues & Volume, By Other, 2021- 2031F |
7 Argentina Neuroendocrine Tumors Market Import-Export Trade Statistics |
7.1 Argentina Neuroendocrine Tumors Market Export to Major Countries |
7.2 Argentina Neuroendocrine Tumors Market Imports from Major Countries |
8 Argentina Neuroendocrine Tumors Market Key Performance Indicators |
8.1 Average time to diagnosis for neuroendocrine tumors patients |
8.2 Patient survival rates post-treatment |
8.3 Adoption rates of emerging diagnostic technologies for neuroendocrine tumors |
8.4 Number of clinical trials conducted for neuroendocrine tumor treatments |
8.5 Patient satisfaction scores with neuroendocrine tumor treatment facilities |
9 Argentina Neuroendocrine Tumors Market - Opportunity Assessment |
9.1 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By Classification, 2021 & 2031F |
9.2 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By Site, 2021 & 2031F |
9.3 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.4 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Argentina Neuroendocrine Tumors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Argentina Neuroendocrine Tumors Market - Competitive Landscape |
10.1 Argentina Neuroendocrine Tumors Market Revenue Share, By Companies, 2024 |
10.2 Argentina Neuroendocrine Tumors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |